Dottikon ES Stock price
Is Dottikon ES a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 9,127 stocks worldwide.
Key metrics
Dottikon ES Stock Analysis
Analyst Opinions
8 Analysts have issued a Dottikon ES forecast:
Analyst Opinions
8 Analysts have issued a Dottikon ES forecast:
Don't miss a Thing! We will send you all news about Dottikon ES directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Company Profile
Dottikon ES Holding AG engages in the development and manufacture of chemicals, intermediates, and pharmaceutical ingredients. The company is headquartered in Dottikon, Aargau and currently employs 841 full-time employees. The company went IPO on 2005-03-31. Its product range includes active pharmaceutical ingredients (APIs) and pharmaceutical intermediates, as well as industrial chemicals. Its pharmaceutical products can be found in medications for, among others, heart disease, asthma, high blood pressure and ulcers. Dottikon ES Holding AG's industrial end products include food additives, cosmetics, electro-chemicals, photo-chemicals and agricultural chemicals. The firm also offers distillation plants and thin layer evaporators for the recycling of solvents, as well as high temperature incinerators for the waste treatment of hazardous waste. As of March 31, 2012, the Company had two wholly owned subsidiaries: DOTTIKON EXCLUSIVE SYNTHESIS AG and DOTTIKON ES MANAGEMENT AG. The company also held a 33.9%-stake in SYSTAG, System Technik AG.
| Head office | Switzerland |
| CEO | Dr. Blocher |
| Employees | 875 |
| Website | dottikon.com |


